Keyword: Stanford University
Backed by results from a small clinical study, Stanford researchers are planning a large trial of AnaptysBio’s anti-IL-33 etokimab in peanut allergy.
Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.
Stanford scientists have identified a molecular defect in Parkinson’s disease and pinpointed a promising drug candidate to target it.
A Stanford team has proposed a strategy for coaxing supporting cells in the brain to transform into memory-preserving neurons.
Stanford researchers discovered that immune cells known for their ability to root out cancer can also kill wayward cells that cause MS.
The week’s biotech news included a map of the human lung that could aid asthma drug development and a compound that thwarts rhinoviruses like colds.
The series A round sets Confo up to advance drugs derived from a novel way of stabilizing GPCRs and performing more sensitive screens.
Inhibiting CD22 may help treat or prevent neurodegenerative diseases by restoring the brain's microglia, a Stanford team found.
Canvassing more than 400,000 people in 8 months, Apple has finished an investigation of its smartwatch’s ability to detect irregular heart rhythms.
A Stanford-led team identified a protein that helps small arteries grow, thereby healing oxygen-starved, damaged heart tissues in mice.